These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1526681)

  • 1. Immunopharmacological activity of cefodizime in young and elderly subjects: in vitro and ex vivo studies.
    Meroni PL; Capsoni F; Borghi MO; Barcellini W; Minonzio F; Ongari AM; Fain C; Hu C; Brambilla G; Pettenati C
    Infection; 1992; 20 Suppl 1():S61-3. PubMed ID: 1526681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cefodizime on non-specific immune functions in patients with multiple myeloma.
    Dammacco F; Benvestito S
    Infection; 1992; 20 Suppl 1():S64-6. PubMed ID: 1526682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of some antibiotics on polymorphonuclear leukocyte functions of elderly patients in vitro before and after zinc supplementation.
    Gürer US; Göçer P; Erçağ E; Erten N; Rayaman E; Gürbüz B; Uzer A; Karan A; Cevikbaş A
    Int Immunopharmacol; 2006 May; 6(5):808-16. PubMed ID: 16546712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and ex vivo enhancement of nonspecific phagocytosis by cefodizime.
    Fietta A; Bersani C; Bertoletti R; Grassi FM; Grassi GG
    Chemotherapy; 1988; 34(5):430-6. PubMed ID: 3053065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefodizime: enhancement of depressed phagocytosis-associated respiratory burst activity in chronic uremic patients.
    Vanholder R; Ringoir S
    Infection; 1992; 20 Suppl 1():S71-4. PubMed ID: 1526684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefodizime enhances phagocytosis and intracellular killing of Staphylococcus aureus but does not influence polymorphonuclear leukocytes response to fMLP stimulation.
    Bialasiewicz P; Stolarek R; Wejner P; Piasecka G; Dutkiewicz B; Mikucki J; Nowak D
    Int J Immunopharmacol; 2000 Jul; 22(7):557-66. PubMed ID: 10785552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefodizime: a new cephalosporin with apparent immune-stimulating properties in chronic renal failure.
    Vanholder R; Van Landschoot N; Dagrosa E; Ringoir S
    Nephrol Dial Transplant; 1988; 3(2):221-4. PubMed ID: 3140091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophoretic mobility of cefodizime-treated Staphylococcus aureus and chemiluminescence of human polymorphonuclear leucocytes.
    Muratsugu M; Tomonaga M; Miyake Y; Terayama K; Ishida N
    J Antimicrob Chemother; 1991 Dec; 28(6):887-96. PubMed ID: 1816185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefodizime host-defence enhancement: considerations of dose-response relationships in healthy volunteers.
    Gialdroni Grassi G; Shah PM
    Infection; 1992; 20 Suppl 1():S51-3. PubMed ID: 1526678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cefodizime on the reagibility of human leukocytes.
    Limbert M; Müllner H; Shah PM
    Infection; 1992; 20 Suppl 1():S48-50. PubMed ID: 1388140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological evaluation of cefodizime: a unique molecule among cephalosporins.
    Labro MT
    Infection; 1992; 20 Suppl 1():S45-7. PubMed ID: 1526677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cefodizime on chemotaxis and the respiratory burst in neutrophils from diabetics.
    Shaio MF; Chang FY
    J Antimicrob Chemother; 1990 Jul; 26(1):55-9. PubMed ID: 2211447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefodizime administration in healthy subjects: studies of natural killer cells, urinary hormones and electrolytes.
    Ventura MM; Romagnoli M; Santucci S; Sforza C; Gatti G; Carandente O
    Chronobiologia; 1988; 15(1-2):43-59. PubMed ID: 2970951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of RO 23-9424, cefotaxime and fleroxacin on functions of human polymorphonuclear cells and cytokine production by human monocytes.
    Matera G; Berlinghieri MC; Foti F; Barreca GS; Focà A
    J Antimicrob Chemother; 1996 Nov; 38(5):799-807. PubMed ID: 8961049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cefotaxime and cefodizime on human granulocyte functions in vitro.
    Labro MT; Babin-Chevaye C; Hakim J
    J Antimicrob Chemother; 1986 Aug; 18(2):233-7. PubMed ID: 3019985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in lymphocyte subpopulations in patients treated with cefodizime for acute lower respiratory tract infections.
    Valcke Y; Van der Straeten M
    Infection; 1992; 20 Suppl 1():S58-60. PubMed ID: 1526680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological effects of cefodizime in patients undergoing antineoplastic chemotherapy.
    Mallmann P; Brühl P
    Infection; 1992; 20 Suppl 1():S67-70. PubMed ID: 1526683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cefodizime on phagocyte function in non-patient volunteers and patients with chronic renal failure. In vitro and ex vivo studies.
    McCafferty AC; McGregor E; Jones M; Henderson IS; Cree IA
    Int J Clin Lab Res; 1996; 26(4):229-35. PubMed ID: 9007612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro.
    Labro MT; el Benna J
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():49-57. PubMed ID: 2127416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotics and energy delivery to the phagocytosis-associated respiratory burst in chronic hemodialysis patients: a comparison of cefodizime and cotrimoxazole.
    Vanholder R; Dagrosa EE; Van Landschoot N; Waterloos MA; Ringoir SM
    Nephron; 1993; 63(1):65-72. PubMed ID: 8446254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.